Clinical trial

Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients

NCT01068483

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-11-01

PhasePHASE1

Study timeline

Study start (unknown)2008-11-01Date precision: month

Registry last updated2020-12-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Colon Cancerunresolved

Ovarian Cancerunresolved

Endometrium Cancerunresolved

Interventions

BKM120DRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

RotterdamNetherlands2 TorontoOntario, Canada1 NashvilleTennessee, United States1 BarcelonaCatalonia, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01068483 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.